However, some studies demonstrated that serum IgG, IgM, or IgA in ALS patients did not differ from control levels [59, 88] or found even lower IgG concentrations in patients with severe disease stage [59]. This evidence concerns the gene CD40LG and amyotrophic lateral sclerosis.